MedTrace Logo

Construction and Validation of a Stress Scale Specific to ICUs: Perceived Stressors in Intensive Care Units (PS-ICU)

NCT02853851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-12-31

No results posted yet for this study

Summary

This study aims to construct and validate an international professional perceived stress scale specific to intensive care units: the PS-ICU Scale (Perceived Stressors in Intensive Care Units).

Conditions

  • Work Stress

Interventions

OTHER

interviews

Each subject will be asked to participate in an individual semidirective interview lasting about 40 minutes on the theme of the stress factors encountered in intensive care. All of the interviews will be audio-taped, transcribed and anonymized. The participants will also have to answer a socio-demographic questionnaire (sex, age, socio-professional category, speciality in intensive care, working hours, family situation, training, diplomas, length of time in the service).

Sponsors & Collaborators

  • Laboratoire de psychologie université de franche Comté

    collaborator UNKNOWN

  • Unité de méthodologie et de qualité de vie en cancérologie CHU de besançon

    collaborator UNKNOWN

  • Hospital de Sabadell Department of Critical Care Spain

    collaborator UNKNOWN

  • Policlinico A. Gemelli Department of Critical Care Italy

    collaborator UNKNOWN

  • Centre hospitalier de l'Université de Montréal (CHUM)

    collaborator OTHER

  • Alfred Hospital Intensive Care Unit Australia

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2021-02-18
Completion
2021-02-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02853851 on ClinicalTrials.gov